Grant Street Asset Management, Inc. Edwards Lifesciences Corp Transaction History

Grant Street Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$101.96 - $128.34 $158,547 - $199,568	-1,555 Closed	0 $0
Q4 2021 Feb 25, 2022	BUY	$106.37 - $130.68 $165,405 - $203,207	1,555 New	1,555 $201,000
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $140,851 - $175,996	-1,680 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$71.69 - $91.23 $120,439 - $153,266	1,680 New	1,680 $153,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Grant Street Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Grant Street Asset Management, Inc. with notifications on news.